| Tag | Content |
|---|
EnhancerAtlas ID | HS194-02739 |
Organism | Homo sapiens |
Tissue/cell | Urothelial_cell |
Coordinate | chr19:36193020-36193820 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| NFYA | MA0060.3 | chr19:36193359-36193370 | GGCCAATCAGA | + | 6.02 | | NFYB | MA0502.1 | chr19:36193471-36193486 | GAGCCAGCCAATCAG | + | 6.04 | | TFAP2A | MA0003.3 | chr19:36193108-36193119 | CGCCTCAGGCT | + | 6.14 |
|
| | Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
| SE_19716 | chr19:36192977-36193968 | CD4p_CD25-_Il17p_PMAstim_Th17 | | SE_59463 | chr19:36184851-36210443 | Ly3 | | SE_61403 | chr19:36184821-36210454 | HBL1 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH19I035701 | chr19 | 36192703 | 36194302 |
|
Enhancer Sequence | TCCCAAAGTG CTGGGATTAC AGGCGTGAGC CACCACGTCC GGCCCCTTCC CCCATTTTAG 60
CGGTTTCGCT CCCTATCGGG GCCAGGGACG CCTCAGGCTG TCTCGGTCAG GACCTACAGC 120
TCCGGTTGTT GTCCCAGGCT CTTCCGCGAG GTGCTCTCCT GTCTCCTGAC CACCCCCATT 180
CCTCCCCACT CCAGCTCCTC AGCGAGCGGC TGCGAAGGAC GCGCACAACA ACACTCCGCG 240
CAGCGGGAAG GTACCGAACT CGCATCGCAG CCTGAAACTG CTCAACTAAG CTCCCGCCCC 300
GCTGCTCTCT GGTCAATCTA AAGCGAAGAC GAGCCTTAGG GCCAATCAGA AGCGACAGCG 360
GTGGAGTCAT GCCCGCCTGC TTGAGGCGCC CTGGCGTCTC ATTGGCTATG CTTGAGAACG 420
AATCCCAGGC TAAGCCACTT AGAAAGGAGC GGAGCCAGCC AATCAGCGGT GCAACCGCCG 480
CGGGGGCCGG GCCAGAAGCC CCGCAGACAA GCACCTCGGG AGACTGGCGA GGGGCGAGCT 540
CGCAGCTTGT TAGCCCCGAA GCCCTGCCCA GGGGGAAACC CTGCTGGAGG GAGTCTAACC 600
CCCGGGCCAG TTAATGTTGG GGCAGCGCAA TCGGCCGTTC CCTCTGCGGT ATGGTTGGAG 660
GTGGGAGTGC TGACACGTCC GCGCGCAGTT ACTCCTGGCT GAGCATACAG TCGAGGTGGC 720
AGTGGGAATT GGAAGTGCAA GTGTCACGCT GCCAATCACG GGGCAAGGCA CTGCCCCCCT 780
CTTGTGTCTT TCCTGTCCCT 800
|
